- Market cap
- $8.79B
- Shares out
- 81.3M
Hinge Health Inc. (HNGE) is an EDP Services company listed on NYSE. In the last 30 days Quantisnow tracked 10 wire items for HNGE, including 6 insider trades, 3 SEC filings and 1 earnings update. The most recent was published Nov 13, 2026.
HNGE rankings
Financial highlights
Full financials- Revenue, TTM
- $800.82M
- Revenue growth
- +49.9%
- Net income, TTM
- $168.31M
- Net margin
- 21.0%
- Free cash flow, TTM
- $322.00M
- Cash
- $211.55M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks82+11%
2026-05-242026-11-15
Mix3890d
- Insider28(74%)
- SEC Filings7(18%)
- Earnings2(5%)
- Analyst1(3%)
Activity · 52 weeks162102 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- INSIDERDirector Robinson Elliott sold 0 shares (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERExec. Chairman & Co-Founder Mecklenburg Gabriel M.I. converted options into 200,000 shares and sold $24,482,097 worth of shares (200,000 units at $122.41) as part of a pre-agreed trading plan (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERChief Financial Officer Budge James sold $4,367,052 worth of shares (35,907 units at $121.62) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 256,207 units (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- SECSEC Form 144 filed by Hinge Health Inc.144 - Hinge Health, Inc. (0001673743) (Subject)
- SECSEC Form 10-Q filed by Hinge Health Inc.10-Q - Hinge Health, Inc. (0001673743) (Filer)
- INSIDERDirector Robinson Elliott sold 0 shares (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERChief Financial Officer Budge James covered exercise/tax liability with 4,614 shares, decreasing direct ownership by 2% to 292,114 units (SEC Form 4) (for withholding tax)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERPresident Pursley James covered exercise/tax liability with 831 shares, decreasing direct ownership by 0.12% to 665,247 units (SEC Form 4) (tax withholding)4 - Hinge Health, Inc. (0001673743) (Issuer)
- SECHinge Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Hinge Health, Inc. (0001673743) (Filer)
- PRHinge Health reports record third quarter 2026 financial resultsRevenue increased 52% year-over-year to $235 million Free cash flow of $113 million, representing a 48% free cash flow margin 2026 revenue guidance midpoint raised to $880 million, reflecting 50% year-over-year growth 2026 non-GAAP operating margin midpoint raised to 30%, reflecting ~1,000 bps improvement year-over-year Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update. "Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale," said Daniel Perez, Co-Founder and CEO, Hinge Health. "
- INSIDERChief Financial Officer Budge James sold $4,921,578 worth of shares (47,720 units at $103.13) as part of a pre-agreed trading plan (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERExec. Chairman & Co-Founder Mecklenburg Gabriel M.I. sold $20,626,371 worth of shares (200,000 units at $103.13) as part of a pre-agreed trading plan (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- SECSEC Form 144 filed by Hinge Health Inc.144 - Hinge Health, Inc. (0001673743) (Subject)
- INSIDERCEO & Co-Founder Perez Daniel Antonio sold $410,811 worth of shares (4,100 units at $100.20) as part of a pre-agreed trading plan (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERSEC Form 4 filed by Hinge Health Inc.4 - Hinge Health, Inc. (0001673743) (Issuer)
- PRHinge Health to announce third quarter 2026 financial results on November 2, 2026Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health’s vision is to scale and automate the delivery of health care. Leverag
- INSIDERPresident Pursley James covered exercise/tax liability with 831 shares, decreasing direct ownership by 0.12% to 666,078 units (SEC Form 4) to satisfy withholding obligation4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERChief Financial Officer Budge James covered exercise/tax liability with 4,614 shares, decreasing direct ownership by 1% to 344,448 units (SEC Form 4) to cover taxes4 - Hinge Health, Inc. (0001673743) (Issuer)
- ANALYSTBofA Securities resumed coverage on Hinge Health with a new price targetBofA Securities resumed coverage of Hinge Health with a rating of Buy and set a new price target of $110.00
- INSIDERPresident Pursley James sold $3,106,504 worth of shares (33,000 units at $94.14) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 666,909 units (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERDirector Robinson Elliott sold 0 shares (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERExec. Chairman & Co-Founder Mecklenburg Gabriel M.I. converted options into 150,000 shares and sold $13,982,810 worth of shares (150,000 units at $93.22) as part of a pre-agreed trading plan (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERExec. Chairman & Co-Founder Mecklenburg Gabriel M.I. converted options into 250,000 shares and sold $22,242,069 worth of shares (250,000 units at $88.97) as part of a pre-agreed trading plan (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERChief Financial Officer Budge James sold $4,969,999 worth of shares (55,561 units at $89.45) as part of a pre-agreed trading plan, decreasing direct ownership by 14% to 349,062 units (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
- INSIDERCEO & Co-Founder Perez Daniel Antonio converted options into 295,000 shares, sold $22,361,643 worth of shares (250,000 units at $89.45) as part of a pre-agreed trading plan and gifted 45,000 shares (SEC Form 4)4 - Hinge Health, Inc. (0001673743) (Issuer)
HNGE FAQ
10 questionsWhat is the latest news on HNGE?
In the last 30 days Quantisnow tracked 10 wire items for HNGE: 6 insider trades, 3 SEC filings and 1 earnings update. The most recent was published on November 13, 2026.What is HNGE revenue?
Hinge Health Inc. (HNGE) reported $800.82M of revenue for the twelve months ended Sep 30, 2026. That is up 49.9% from the year before. Revenue for fiscal 2025 was $587.86M.Is HNGE profitable?
Yes. Hinge Health Inc. earned $168.31M in net income for the twelve months ended Sep 30, 2026, a net margin of 21.0%.How much cash and debt does HNGE have?
Hinge Health Inc. reported $211.55M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does HNGE stock trade?
Hinge Health Inc. (HNGE) is listed on NYSE.What sector and industry is HNGE in?
Hinge Health Inc. operates in the Technology sector, EDP Services industry.When did Hinge Health Inc. go public?
Hinge Health Inc. (HNGE) completed its IPO in 2025.What are analysts saying about HNGE?
Hinge Health Inc. has had 8 recent analyst actions on file. The most recent action was from BofA Securities: Buy with a $110.00 price target on 2026-09-29. Recent price targets range from $45.00 to $110.00.What companies are similar to HNGE?
Notable peers in the same industry include TDOC (Teladoc Health Inc.), OMDA (Omada Health Inc.), LFMD (LifeMD Inc.), PGNY (Progyny Inc.). Compare HNGE side-by-side with any of them on Quantisnow.How can I track HNGE on Quantisnow?
Quantisnow aggregates Hinge Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HNGE to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change